Amplia Therapeutics Limited (INNMF)

Amplia Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 2, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	75	17	10	11	21	21
Market Cap Growth	73.87%	73.87%	-11.90%	-47.57%	-1.30%	803.50%
Enterprise Value	68	14	8	5	19	19
Last Close Price	0.15	0.05	0.05	0.07	0.11	0.19
PS Ratio	31.83	7.18	3.36	13.86	14.17	18.31
PB Ratio	5.73	1.29	1.31	1.04	1.29	2.72
P/TBV Ratio	9.20	2.08	4.29	2.09	2.02	11.69
EV/Sales Ratio	27.44	5.99	2.59	5.99	12.57	15.85
Debt / Equity Ratio	0.00	0.00	0.14	0.14	0.10	-
Asset Turnover	0.20	0.20	0.27	0.06	0.11	0.15
Quick Ratio	7.75	7.75	1.93	3.78	31.03	5.28
Current Ratio	7.91	7.91	1.98	3.82	31.18	5.45
Return on Equity (ROE)	-40.51%	-40.51%	-33.05%	-33.13%	-22.64%	-24.08%
Return on Assets (ROA)	-22.47%	-22.47%	-17.04%	-18.20%	-12.88%	-14.63%
Return on Capital (ROIC)	-24.94%	-24.94%	-18.36%	-18.68%	-13.28%	-15.44%
Earnings Yield	-5.46%	-24.20%	-30.15%	-37.85%	-12.96%	-8.13%
FCF Yield	-5.72%	-25.36%	-34.34%	-32.18%	-15.71%	-10.41%
Buyback Yield / Dilution	-58.35%	-58.35%	-0.02%	-33.27%	-53.71%	-95.36%

Updated Nov 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.